Both in Pharmaceuticals
Faeth Therapeutics vs Evolus
Over the past year FTH returned −50.1% and EOLS returned −6.3%; their daily moves had a correlation of 0.41.
FTH −50.1% EOLS −6.3%Growth of $1, one year, split-adjusted
| Metric | FTH | EOLS |
|---|---|---|
| Price | $18.69 | $7.35 |
| Market cap | $483.0M | $485.5M |
| Today | −0.32% | −2.26% |
| 1 month | −33.9% | −4.4% |
| 6 months | — | +37.9% |
| Year to date | — | +10.5% |
| 1 year | — | +7.1% |
| Revenue growth (YoY) | — | +21.2% |
| Gross margin | — | 68.0% |
| Net margin | — | −9.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.5× |
| Net cash | $186.4M | -$141.9M |
| Dividend yield | — | — |
| Volatility (60d) | — | 52.4% |
| Short % of float | 16.6% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).